• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用合成生物学工具选择性诱导细胞程序性死亡。

Selective induction of programmed cell death using synthetic biology tools.

机构信息

Institute of Innate Immunity, University Hospital Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Department of Immunobiology, University of Lausanne, Switzerland.

出版信息

Semin Cell Dev Biol. 2024 Mar 15;156:74-92. doi: 10.1016/j.semcdb.2023.07.012. Epub 2023 Aug 17.

DOI:10.1016/j.semcdb.2023.07.012
PMID:37598045
Abstract

Regulated cell death (RCD) controls the removal of dispensable, infected or malignant cells, and is thus essential for development, homeostasis and immunity of multicellular organisms. Over the last years different forms of RCD have been described (among them apoptosis, necroptosis, pyroptosis and ferroptosis), and the cellular signaling pathways that control their induction and execution have been characterized at the molecular level. It has also become apparent that different forms of RCD differ in their capacity to elicit inflammation or an immune response, and that RCD pathways show a remarkable plasticity. Biochemical and genetic studies revealed that inhibition of a given pathway often results in the activation of back-up cell death mechanisms, highlighting close interconnectivity based on shared signaling components and the assembly of multivalent signaling platforms that can initiate different forms of RCD. Due to this interconnectivity and the pleiotropic effects of 'classical' cell death inducers, it is challenging to study RCD pathways in isolation. This has led to the development of tools based on synthetic biology that allow the targeted induction of RCD using chemogenetic or optogenetic methods. Here we discuss recent advances in the development of such toolset, highlighting their advantages and limitations, and their application for the study of RCD in cells and animals.

摘要

细胞程序性死亡(RCD)控制着多余的、感染的或恶性细胞的清除,因此对多细胞生物的发育、稳态和免疫至关重要。在过去的几年中,已经描述了不同形式的 RCD(包括细胞凋亡、细胞坏死性凋亡、细胞焦亡和铁死亡),并且已经在分子水平上描述了控制其诱导和执行的细胞信号通路。不同形式的 RCD 在引发炎症或免疫反应的能力上也存在差异,而且 RCD 途径具有显著的可塑性,这一点也变得显而易见。生化和遗传学研究表明,抑制特定途径通常会导致备用细胞死亡机制的激活,这突出了基于共享信号成分的紧密相互连接性和能够引发不同形式 RCD 的多价信号平台的组装。由于这种相互连接性和“经典”细胞死亡诱导剂的多效性效应,单独研究 RCD 途径具有挑战性。这导致了基于合成生物学的工具的开发,这些工具允许使用化学遗传学或光遗传学方法靶向诱导 RCD。在这里,我们讨论了此类工具集的最新进展,突出了它们的优点和局限性,以及它们在细胞和动物中 RCD 研究中的应用。

相似文献

1
Selective induction of programmed cell death using synthetic biology tools.使用合成生物学工具选择性诱导细胞程序性死亡。
Semin Cell Dev Biol. 2024 Mar 15;156:74-92. doi: 10.1016/j.semcdb.2023.07.012. Epub 2023 Aug 17.
2
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.针对癌症治疗的细胞死亡途径:细胞坏死、细胞焦亡、铁死亡和铜死亡研究的新进展。
J Hematol Oncol. 2022 Dec 8;15(1):174. doi: 10.1186/s13045-022-01392-3.
3
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance.细胞焦亡、铁死亡和细胞坏死在乳腺癌中的新作用:克服治疗耐药性的新曙光。
Neoplasia. 2024 Sep;55:101017. doi: 10.1016/j.neo.2024.101017. Epub 2024 Jun 14.
4
Regulated cell death: discovery, features and implications for neurodegenerative diseases.调控细胞死亡:发现、特征及其对神经退行性疾病的影响。
Cell Commun Signal. 2021 Dec 18;19(1):120. doi: 10.1186/s12964-021-00799-8.
5
Innate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease.先天免疫炎症细胞死亡:宿主防御和疾病中的 PANoptosis 和 PANoptosomes。
Eur J Immunol. 2023 Nov;53(11):e2250235. doi: 10.1002/eji.202250235. Epub 2023 Mar 3.
6
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.用小分子化合物靶向三阴性乳腺癌中的调控细胞死亡(RCD):从分子机制到靶向治疗的再思考视角。
J Hematol Oncol. 2022 Apr 12;15(1):44. doi: 10.1186/s13045-022-01260-0.
7
Mechanisms of Regulated Cell Death: Current Perspectives.细胞程序性死亡机制:当前观点
Vet Pathol. 2021 Jul;58(4):596-623. doi: 10.1177/03009858211005537. Epub 2021 May 27.
8
Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis.调控细胞死亡及其在阿尔茨海默病和肌萎缩性侧索硬化症中的作用。
Acta Neuropathol. 2024 Apr 7;147(1):69. doi: 10.1007/s00401-024-02722-0.
9
Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis.过度的磷脂过氧化将铁死亡与包括细胞焦亡在内的其他细胞死亡方式区分开来。
Cell Death Dis. 2020 Oct 27;11(10):922. doi: 10.1038/s41419-020-03118-0.
10
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.肿瘤免疫治疗中的自噬、铁死亡、细胞焦亡和坏死性凋亡。
Signal Transduct Target Ther. 2022 Jun 20;7(1):196. doi: 10.1038/s41392-022-01046-3.

引用本文的文献

1
Engineering development: From the repressilator and toggle switch to synthetic developmental biology.工程学发展:从基因抑制回路和拨动开关到合成发育生物学
Dev Biol. 2025 Oct;526:82-97. doi: 10.1016/j.ydbio.2025.06.021. Epub 2025 Jun 25.
2
Optogenetic engineering for precision cancer immunotherapy.用于精准癌症免疫治疗的光遗传学工程
Trends Pharmacol Sci. 2025 Jun 10. doi: 10.1016/j.tips.2025.05.002.
3
Identification of programmed cell death-related genes and construction of a prognostic model in oral squamous cell carcinoma using single-cell and transcriptome analysis.
利用单细胞和转录组分析鉴定口腔鳞状细胞癌中程序性细胞死亡相关基因并构建预后模型
Discov Oncol. 2025 May 9;16(1):713. doi: 10.1007/s12672-025-02520-4.
4
Parthanatos and apoptosis: unraveling their roles in cancer cell death and therapy resistance.PARP-1依赖性细胞坏死与细胞凋亡:揭示它们在癌细胞死亡和治疗抗性中的作用
EXCLI J. 2025 Mar 4;24:351-380. doi: 10.17179/excli2025-8251. eCollection 2025.
5
Targeted Activation of Programmed Cell Death Pathways by Optogenetics.通过光遗传学对程序性细胞死亡途径进行靶向激活
Methods Mol Biol. 2025;2840:57-74. doi: 10.1007/978-1-0716-4047-0_5.
6
Sinomenine Hydrochloride Protects IgA Nephropathy Through Regulating Cell Growth and Apoptosis of T and B Lymphocytes.盐酸青藤碱通过调节T和B淋巴细胞的细胞生长及凋亡来保护IgA肾病。
Drug Des Devel Ther. 2024 Apr 17;18:1247-1262. doi: 10.2147/DDDT.S449119. eCollection 2024.